Home - Products - Metabolic Enzyme/Protease - PPAR - Gemfibrozil

Gemfibrozil

CAS No. 25812-30-0

Gemfibrozil( CI-719 | Lopid )

Catalog No. M13780 CAS No. 25812-30-0

Gemfibrozil (Lopid) is an oral drug used to lower lipid levels.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	48	In Stock
25MG	29	In Stock
50MG	35	In Stock
100MG	47	In Stock
200MG	59	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Gemfibrozil
Note

Research use only, not for human use.
Brief Description

Gemfibrozil (Lopid) is an oral drug used to lower lipid levels.
Description

Gemfibrozil (Lopid) is an oral drug used to lower lipid levels. It belongs to a group of drugs known as fibrates. Increases activity of Peroxisome proliferator-activated receptor-alpha (PPARα) 'transcription factor ligand' , a receptor that is involved in metabolism of carbohydrates and fats, as well as adipose tissue differentiation. This increase in the synthesis of lipoprotein lipase thereby increases the clearance of triglycerides.
In Vitro

——
In Vivo

——
Synonyms

CI-719 | Lopid
Pathway

Metabolic Enzyme/Protease
Target

PPAR
Recptor

PPARα
Research Area

Metabolic Disease
Indication

——

Chemical Information

CAS Number

25812-30-0
Formula Weight

250.33
Molecular Formula

C15H22O3
Purity

>98% (HPLC)
Solubility

Ethanol: 50 mg/mL (199.73 mM); DMSO: 50 mg/mL (199.73 mM)
SMILES

CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
Chemical Name

5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Clavey V, et al. Cell Physiol Biochem. 1999;9(3):139-49.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

GW590735

GW590735 is an effective and selective PPARα agonist with an EC50 of 4 nM on PPARα and at least 500-fold selectivity versus PPARδ and PPARγ. GW590735 can be used in dyslipidemia studies.
GW7647

GW7647 is a potent agonist of PPARα (EC50s: 6 nM, 1.1 μM, and 6.2 μM for human PPARα, PPARγ, and PPARδ, respectively).GW7647 (50 nM) stimulates the PI3K phosphorylation followed by the Akt (Ser473) phosphorylation, which causes NOS1 phosphorylation increased the amounts of NO released in the stripped antral mucosa.
Muraglitazar

Muraglitazar (BMS-298585) is a PPAR α/γ dual agonist for the treatment of type 2 diabetes and associated dyslipidemia.

Sign In Join Free